Biotechnology What’s Going On With Cancer Focused-Geron Stock On Friday? – Geron (NASDAQ:GERN) Read more
Biotechnology Gilead’s Aggressive Push Beyond HIV Treatments – Plans To Increase Cancer-Focused CAR-T Treatment Production – Gilead Sciences (NASDAQ:GILD) Read more
Biotechnology Newly Diagnosed Cervical Cancer Patients – Merck’s Blockbuster Drug Keytruda Plus Chemoradiotherapy Improves Overall Survival – Merck & Co (NYSE:MRK) Read more
Biotechnology Fed Agency Grants $14M To Gilgamesh For Cardiac-Safe Ibogaine Analog Targeting Opioid Use Disorder Read more
Biotechnology Cancer Treatment Focused Immuneering Faces Analyst Downgrades, Who Cite Underwhelming Solid Tumor Trial Data – Immuneering (NASDAQ:IMRX) Read more
Biotechnology FDA Approves BeiGene’s First Drug Candidate Produced Through Its Immuno-Oncology Program For Esophageal Cancer – BeiGene (NASDAQ:BGNE) Read more
Biotechnology Bristol Myers’ Breyanzi Scores Second FDA Approval For Blood Cancers Therapy – Bristol-Myers Squibb (NYSE:BMY) Read more
Biotechnology Why Is Madrigal Pharmaceuticals Stock Trading Higher On Friday? – Madrigal Pharmaceuticals (NASDAQ:MDGL) Read more
Biotechnology Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Entered Into A Definitive Mutual Release And Settlement Agreement With Virpax Pharmaceuticals, Inc. Relating To The Previously Announced Term Sheet With Virpax In Respect Of Such Release And Settlement – Scilex Holding (NASDAQ:SCLX) Read more
Biotechnology Candel Therapeutics (NASDAQ: CADL) Lead Product Candidate CAN-3110 Demonstrates Promise To Treat Deadly Brain Tumors – Candel Therapeutics (NASDAQ:CADL) Read more